Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 7Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Hypoparathyroidism 2Carcinoma, Squamous Cell 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Diseases 1Recurrence 1Rectal Neoplasms 1Parathyroid Diseases 1Ovarian Neoplasms 1Neovascularization, Pathologic 1Melanoma 1Margins of Excision 1Lymphedema 1Head and Neck Carcinoma 1Graves Disease 1Goiter 1Endometrial Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1Adenoma 1

Interventions

Bupivacaine 2acetaminophen, codeine drug combination 1Triiodothyronine 1Tramadol 1Thyroxine 1Thyroidectomy 1Ropivacaine 1Remote Consultation 1Negative-Pressure Wound Therapy 1Ketorolac 1Indocyanine Green 1Hyaluronic Acid 1Glucose 1Epinephrine 1Dexmedetomidine 1Data Collection 1Clinical Protocols 1Capsules 1Calcium Carbonate 1Calcitriol 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Goiter × Indocyanine Green × Head & Neck × Clear all
NCT03969108 2020-03-27

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

University Health Network, Toronto

Phase 4 Completed
10 enrolled
Head & Neck

Goiter, Graves Disease, Hypoparathyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡